Skip to content
Annika Bansal – Lifestyle
Author:
AbbVie Inc.
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
March 6, 2026
AbbVie to Present at the Leerink Partners Global Healthcare Conference
March 5, 2026
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn’s Disease
March 5, 2026
←
Previous Page
1
2
3